Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.06B
Revenue (ttm)	1.77B
Net Income (ttm)	324.56M
Shares Out	230.99M
EPS (ttm)	1.40
PE Ratio	6.36
Forward PE	6.90
Dividend	0.36 (3.98%)
Ex-Dividend Date	Dec 19, 2025

Volume	534,700
Average Volume	668,813
Open	9.04
Previous Close	9.01
Day's Range	8.88 - 9.20
52-Week Range	8.83 - 11.51
Beta	0.42
RSI	33.58
Earnings Date	Mar 18, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.